# Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus

Study · id `cardio:ct-nct04660240` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04660240](<https://clinicaltrials.gov/study/NCT04660240>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04660240

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 860 participants.

## Technical summary

Registry record NCT04660240. Randomized; single masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 860 participants (planned count; ClinicalTrials.gov record NCT04660240, source copy `cardio:ctgov-nct04660240-2024-02-20`, retrieved 2026-10-26)
- Started: 2020-10-01 (actual) (ClinicalTrials.gov record NCT04660240, source copy `cardio:ctgov-nct04660240-2024-02-20`, retrieved 2026-10-26)
- Primary completion: 2025-05-01 (anticipated) (ClinicalTrials.gov record NCT04660240, source copy `cardio:ctgov-nct04660240-2024-02-20`, retrieved 2026-10-26)
- Completion: 2025-09-01 (anticipated) (ClinicalTrials.gov record NCT04660240, source copy `cardio:ctgov-nct04660240-2024-02-20`, retrieved 2026-10-26)
- Countries: Mexico (ClinicalTrials.gov record NCT04660240, source copy `cardio:ctgov-nct04660240-2024-02-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04660240-2024-02-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus
- Acronym: INC-DM
- Condition: Diabetes Mellitus
- Condition: Coronary Artery Disease
- Condition: Acute Coronary Syndrome
- Intervention (Device): Abluminus Sirolimus Eluting Stent System (ASES)
- Intervention (Device): Orsiro Sirolimus Eluting Coronary Stent System (OSES)
- Lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez (`cardio:org-instituto-nacional-de-cardiologia-ignacio-chavez`)

## Provenance

Content hash: 3b731aa2fd6a6f91ff826e99b9b5ffa525ec1d8e5d8c41dab669a59bf9560cb7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
